Known As:Bone morphogenetic protein 4; BMP-4; BMP4; BMP2B; DVR4
PROPERTIES
Description:Recombinant Human Bone morphogenetic protein 4 is produced by our E.coli
expression system and the target gene encoding Ser293-Arg408.
Accession:P12644
Formulation:Supplied as a 0.2 μm filtered solution of 4mM HCl.
Size:10µg/50µg/500µg/1mg
Purity:> 95%
Endotoxin:< 0.01 EU/µg as determined by LAL test.
Predicted Mol Mass:13.3 KDa
Apparent Mol Mass:12-14 KDa, reducing conditions
Shipping:The product is shipped on dry ice/polar packs.
Upon receipt, store it immediately at the temperature listed below.
Storage:Store at ≤-70°C, stable for 6 months after receipt.
Store at ≤-70°C, stable for 3 months under sterile conditions after opening.
Please minimize freeze-thaw cycles
Background:Bone morphogenic protein-4 (BMP-4) is one of nine structurally related BMPs belonging to the transforming growth factor-beta (TGF-beta) superfamily of secreted proteins. Mature BMP-4 is a dimer that binds to a multimeric transmembrane receptor with serine/threonine kinase activity. BMP-4 has important roles as a signalling molecule in embryonic tissues, including the developing central and peripheral nervous system, musculature and skeleton. BMP-4 as well as its receptors and their signal transduction pathways play a crucial role in the control of the differentiation and proliferation of the different cell types that constitute the anterior pituitary.
NOTE:The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
